MI:RNA Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$4.51M
- Investors
-
12
MI:RNA General Information
Description
Operator of a veterinary diagnostics company intended to develop and market testing technology for early-stage heart disease in companion animals. The company specializes in the development of testing technology for veterinary diseases and it offers companion animal tests using serum biomarkers and AI modeling, enabling pets to improve treatment outcomes and quality of life for pets.
Contact Information
Website
mirna-diagnostics.comCorporate Office
- Scotland's Rural College, Room 16
- Peter Wilson Building Basement, West Mains Road
- Edinburgh EH9 3JG
- Scotland, United Kingdom
Corporate Office
- Scotland's Rural College, Room 16
- Peter Wilson Building Basement, West Mains Road
- Edinburgh EH9 3JG
- Scotland, United Kingdom
MI:RNA Timeline
MI:RNA Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series A) | 03-Jul-2024 | $4.51M | Completed | Generating Revenue | ||
| 2. Seed Round | 01-Aug-2023 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 04-Mar-2023 | $200K | $200K | Completed | Generating Revenue |
MI:RNA Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Series A2 | ||||||||
| Series A1 | ||||||||
| Ordinary | 26,267 | $0.001270 | $26.58 | $26.58 | 1x | $26.58 | 10.44% | |
| Ordinary | 7,421 | $0.001270 | $18.48 | $18.48 | 1x | $18.48 | 2.95% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
MI:RNA Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MI:RNA Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Animal Health Angels | Angel Group | Minority | ||
| Gabriel Investment Syndicate | Angel Group | Minority | ||
| Kyoritsu Holdings | Corporation | Minority | ||
| NovaQuest Capital Management | PE/Buyout | Minority | ||
| Vane | VC-Backed Company | Minority |
MI:RNA FAQs
-
When was MI:RNA founded?
MI:RNA was founded in 2019.
-
Where is MI:RNA headquartered?
MI:RNA is headquartered in Edinburgh, United Kingdom.
-
What is the size of MI:RNA?
MI:RNA has 4 total employees.
-
What industry is MI:RNA in?
MI:RNA’s primary industry is Other Services (B2C Non-Financial).
-
Is MI:RNA a private or public company?
MI:RNA is a Private company.
-
What is the current valuation of MI:RNA?
The current valuation of MI:RNA is .
-
What is MI:RNA’s current revenue?
The current revenue for MI:RNA is .
-
How much funding has MI:RNA raised over time?
MI:RNA has raised $5.55M.
-
Who are MI:RNA’s investors?
Animal Health Angels, Gabriel Investment Syndicate, Kyoritsu Holdings, NovaQuest Capital Management, and Vane are 5 of 12 investors who have invested in MI:RNA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
